HPV-16
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions (NCT03197025) | National Cancer Institute (NCI) | 2018-01-09 |
Track HPV-16 automatically
Every clearance here is in the API, with alerts when new ones post.